Omada Health
OMDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $169,800 | $122,784 | $89,185 |
| % Growth | 38.3% | 37.7% | – |
| Cost of Goods Sold | $66,923 | $52,813 | $46,394 |
| Gross Profit | $102,877 | $69,971 | $42,791 |
| % Margin | 60.6% | 57% | 48% |
| R&D Expenses | $35,923 | $33,738 | $26,168 |
| G&A Expenses | $42,555 | $35,981 | $30,489 |
| SG&A Expenses | $110,608 | $102,230 | $88,973 |
| Sales & Mktg Exp. | $68,053 | $66,249 | $58,484 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $146,531 | $135,968 | $115,141 |
| Operating Income | -$43,654 | -$65,997 | -$72,350 |
| % Margin | -25.7% | -53.8% | -81.1% |
| Other Income/Exp. Net | -$3,483 | -$1,514 | -$168 |
| Pre-Tax Income | -$47,137 | -$67,511 | -$72,518 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$47,137 | -$67,511 | -$72,518 |
| % Margin | -27.8% | -55% | -81.3% |
| EPS | -0.85 | -1.21 | -1.3 |
| % Growth | 29.8% | 6.9% | – |
| EPS Diluted | -0.85 | -1.21 | -1.3 |
| Weighted Avg Shares Out | 55,744 | 55,744 | 55,744 |
| Weighted Avg Shares Out Dil | 55,744 | 55,744 | 55,744 |
| Supplemental Information | – | – | – |
| Interest Income | $805 | $5,775 | $2,202 |
| Interest Expense | $4,506 | $4,705 | $4,201 |
| Depreciation & Amortization | $4,803 | $4,448 | $4,331 |
| EBITDA | -$37,828 | -$58,358 | -$63,986 |
| % Margin | -22.3% | -47.5% | -71.7% |